Commodore Capital LP Xenon Pharmaceuticals Inc. Transaction History

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024

A detailed history of Commodore Capital LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Commodore Capital LP holds 2,700,000 shares of XENE stock, worth $103 Million. This represents 9.03% of its overall portfolio holdings.

Number of Shares
2,700,000
Previous 2,754,266 1.97%
Holding current value
$103 Million
Previous $107 Million 1.06%
% of portfolio
9.03%
Previous 9.63%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$36.12 - $43.96 $1.96 Million - $2.39 Million
-54,266 Reduced 1.97%
2,700,000 $106 Million
Q2 2024

Aug 14, 2024
BUY
$36.25 - $43.75 $21.3 Million - $25.7 Million
586,473 Added 27.05%
2,754,266 $107 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $9.26 Million - $15 Million
322,793 Added 17.5%
2,167,793 $99.8 Million
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $6.22 Million - $7.5 Million
185,889 Added 11.2%
1,845,000 $66 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $2.12 Million - $2.53 Million
64,179 Added 4.02%
1,659,111 $65.4 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $9.98 Million - $13.8 Million
392,319 Added 32.62%
1,594,932 $48.5 Million
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $2.82 Million - $3.73 Million
112,487 Added 10.32%
1,202,613 $36.8 Million
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $7.97 Million - $18.1 Million
510,694 Added 88.14%
1,090,126 $34.1 Million
Q3 2021

Nov 15, 2021
BUY
$14.86 - $19.45 $3.76 Million - $4.92 Million
253,096 Added 77.56%
579,432 $8.85 Million
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $419,308 - $498,880
24,944 Added 8.28%
326,336 $6.08 Million
Q1 2021

May 17, 2021
SELL
$13.65 - $21.31 $2.27 Million - $3.54 Million
-165,976 Reduced 35.51%
301,392 $5.4 Million
Q4 2020

Feb 16, 2021
BUY
$9.49 - $16.04 $4.44 Million - $7.5 Million
467,368 New
467,368 $7.19 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.37B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email